Status:
NOT_YET_RECRUITING
Rapid Diagnostic Technology for AUGIB Based on Analysis of VOCs in Exhaled Breath
Lead Sponsor:
Beijing 302 Hospital
Conditions:
Volatile Organic Compound
Gastrointestinal Hemorrhage
Eligibility:
All Genders
18+ years
Brief Summary
This study aims to develop a non-invasive and rapid diagnostic technology for acute upper gastrointestinal bleeding (AUGIB) by analyzing volatile organic compounds (VOCs) in exhaled breath. Clinically...
Detailed Description
Acute upper gastrointestinal bleeding (AUGIB) is a common emergency with an annual incidence of 100-180/100,000 and mortality of 2%-15%. Endoscopy, the gold standard, is invasive and equipment-depende...
Eligibility Criteria
Inclusion
- Age ≥18 years;
- Clinical suspicion of AUGIB (e.g., hematemesis, melena);
- Fasting ≥4 hours;
- Signed informed consent.
Exclusion
- Severe pulmonary dysfunction or recent lung infection (within 1 week);
- Cardiac/renal failure or disseminated intravascular coagulation;
- Contraindications to endoscopy;
- High-risk conditions (e.g., massive ascites);
- Alcohol consumption within 24 hours;
- Pregnancy.
Key Trial Info
Start Date :
March 20 2025
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
July 20 2025
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT06877507
Start Date
March 20 2025
End Date
July 20 2025
Last Update
March 14 2025
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.